Ceramide biosynthetic process

pathway activity — cross-omics
GO:0046513Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Ceramide biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Leukemia cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PICALM, NFE2, and CFH, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Ceramide biosynthetic process activity versus PICALM in BLOOD_Leukemia (Pearson r = 0.57).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaPICALM →+1.159+0.852<.001.00134
BLOOD_LeukemiaNFE2 →+3.497+1.202<.001<.00134
CNSCFH →+3.596+1.460<.001<.00133
BLOOD_LeukemiaMINPP1 →+2.167+1.400<.001<.00133
BLOOD_LymphomaCD72 →-2.164-0.856.004<.00133
BLOOD_LymphomaC1RL →+1.440+0.741.002.00333
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0046513 vs PICALM — BLOOD_Leukemia

Per-sample scatter of Ceramide biosynthetic process activity vs PICALM in BLOOD_Leukemia.

Explore this scatter interactively →

Exploration